LIMK1 and ovarian carcinoma: Moreover, Chen et al. [18] indicated that miR-138 could directly target LIM kinase 1 (Limk1) and inhibited metastasis of ovarian cancer by Limk1/cofilin/p-cofilin signaling pathway.